Advances in Pancreatic Cancer: Expert Insights to Guide Clinical Practice

Get up to date on key topics in the contemporary management of patients with resectable and advanced pancreatic cancer with downloadable slides expert interactive virtual presentations and an Interactive Decision Support Tool.

Share

Program Content

Activities

Updates in Pancreatic Ca
Key Topics in the Management of Patients With Resectable and Advanced Pancreatic Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Activities

1L Therapy for mPanC
Slides: Current First-line Treatment Options for Metastatic Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2021

Expires: February 16, 2022

2L Therapy for mPanC
Slides: Current Second-line Treatment Options for Metastatic Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

Neoadjuvant/Adjuvant
Slides: Neoadjuvant and Adjuvant Therapy Strategies for Patients with Resectable Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

PARPi Maintenance
Slides: The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients with Advanced Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 05, 2021

Expires: March 04, 2022

Activities

Pancreatic Cancer Tool
Expert Guidance for the Treatment of Pancreatic Cancer
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: September 13, 2021

Expires: September 12, 2022

Activities

1L Therapy for mPanC
Current Therapeutic Options for Metastatic Pancreatic Cancer: First-line Treatment
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2021

Expires: February 16, 2022

2L Therapy for mPanC
Current Therapeutic Options for Metastatic Pancreatic Cancer: Second-line Treatment
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

Neoadjuvant/Adjuvant
Neoadjuvant and Adjuvant Therapy Strategies for Patients With Resectable Pancreatic Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

PARPi Maintenance
The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients With Advanced Pancreatic Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 05, 2021

Expires: March 04, 2022

Faculty

cover img faculity

Andrew H. Ko, MD

Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Paul E. Oberstein, MD

Assistant Professor of Medicine
Division of Hematology/Medical Oncology
NYU Langone Health
Director, GI Medical Oncology
NYU Perlmutter Comprehensive Cancer Center
NYU Langone Healthy
New York, New York

cover img faculity

Elena Gabriela Chiorean, MD

Professor of Medicine
Division of Medical Oncology
Department of Medicine
University of Washington
Member
Fred Hutchinson Cancer Research
Seattle, Washington

cover img faculity

Andrew Ko

cover img faculity

Dan Laheru, MD

Associate Professor
Department of Oncology/Medical Oncology
Johns Hopkins University, School of Medicine
Oncologist
Department of Oncology/Medical Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Baltimore, Maryland

cover img faculity

Michael Pishvaian, MD, PhD

Associate Professor
Department of Oncology
Director
Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs
NCR Kimmel Cancer Center
Sibley Memorial Hospital
The Johns Hopkins University School of Medicine
Washington, DC

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Ipsen Biopharmaceuticals Inc